Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Cystoealstometer (Bladder Monitor Device)-Home Use

NCT: NCT05232253 · ACTIVE_NOT_RECRUITING

NCT IDNCT05232253
StatusACTIVE_NOT_RECRUITING
Start Date2021-01-18
Completion2028-02-01
SponsorUniversity of Iowa (OTHER)
First posted
Last updated

Brief Summary

The investigators have developed a novel pressure monitoring device called a 'cystoelastometer' that connects to a drainage end ofastandard urinary catheters that are used by patients with a neurogenic bladder on daily clean intermittent catheterization. The device has already been demonstrated to be accurate in measuring bladder pressure compared to the gold standard urodynamics that are performed in the clinic or hospital. This study will assess the patients and care givers ability and experience using the cystoelastometer device in a home setting.

Frequently Asked Questions

What is Cystoealstometer (Bladder Monitor Device)-Home Use?

Cystoealstometer (Bladder Monitor Device)-Home Use is a clinical trial registered under NCT05232253. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT05232253?

The current status of NCT05232253 (Cystoealstometer (Bladder Monitor Device)-Home Use) is: ACTIVE_NOT_RECRUITING.

When did Cystoealstometer (Bladder Monitor Device)-Home Use start?

Cystoealstometer (Bladder Monitor Device)-Home Use started on 2021-01-18.

Related Devices

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.